Home BociMed

BociMed

In operation
Equity Financing
Pharmaceutical R&D and Production Service Provider
Basic
Enterprise Profile

Basic Information

BociMed, as a drug research and development and production service (CRO/CDMO) company focused on improved new drugs, innovative drugs, and high-end formulations, is committed to building an international and cutting-edge pharmaceutical R&D and innovation platform. With extensive development experience in the fields of oncology, cardiovascular, immunology, neurology, and psychiatry, BociMed also possesses rich professional expertise and innovative technological advantages in advanced formulation technologies (such as oral sustained-release and controlled-release, oral solid solubilization, long-acting injections, liquids, semi-solids, etc.).
BociMed
Shanghai,China
101~500 people
September 19, 2012
jiajun.song@bocimed.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Drug Active Pharmaceutical Ingredients Production of Pharmaceutical Intermediates CRO CDMO
Technology
Artificial Intelligence
Concept
Tumor Cardiovascular Disease Immune System Diseases Mental Disorders # Nervous System Diseases Therapeutic Products
Application Scenarios
Active Pharmaceutical Ingredient (API) Innovative Drugs